Dmax: A simple and reliable PET/CT-derived new biomarker of lymphoma outcome?

Ceriani, Luca; Zucca, Emanuele (2022). Dmax: A simple and reliable PET/CT-derived new biomarker of lymphoma outcome? Hematological oncology, 40(5), pp. 843-845. Wiley 10.1002/hon.3049

[img]
Preview
Text
Hematological_Oncology_-_2022_-_Ceriani_-_Dmax_A_simple_and_reliable_PET_CT_derived_new_biomarker_of_lymphoma_outcome.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (712kB) | Preview

No abstract. This article is protected by copyright. All rights reserved.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

ISSN:

1099-1069

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

19 Jul 2022 07:24

Last Modified:

15 Jul 2023 00:25

Publisher DOI:

10.1002/hon.3049

PubMed ID:

35829670

Uncontrolled Keywords:

18FDG-PET/CT Dmax HL PET metrics prognostic models

BORIS DOI:

10.48350/171300

URI:

https://boris.unibe.ch/id/eprint/171300

Actions (login required)

Edit item Edit item
Provide Feedback